Children now eligible for screening test for bacterium

(HealthDay) -- The U.S. Food and Drug Administration has expanded approval for a breath test that screens for a common ulcer-causing germ, to include children aged 3 years to 17.

The bacterium causes stomach inflammation (gastritis) and ulcers, and increases an infected person's risk of and a certain form of lymphoma. In a news release, the FDA said the BreathTak UBT test, approved for adults in 1996, is now sanctioned for children.

The U.S. Centers for Disease Control and Prevention estimates that more than two-thirds of the world's population is infected with the bacterium, abbreviated H. pylori, but most infected people never have symptoms, the FDA said.

The BreathTek UBT test was newly approved based on results from a multi-location clinical trial involving 176 children, the agency said.

The test is produced by Otsuka America Pharmaceutical, headquartered in Rockville, Md.

More information: To learn more about H. Pylori, visit the CDC.

add to favorites email to friend print save as pdf

Related Stories

Peptic ulcer bacterium alters the body's defense system

Jun 29, 2009

Helicobacter pylori survives in the body by manipulating important immune system cells. This is shown in a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden. The discovery may lead to new treatm ...

Preventing gastric cancer with antibiotics

Mar 12, 2010

Helicobacter pylori, a bacterium found in about 50% of humans worldwide, can cause stomach ulcers and, in extreme cases, gastric cancer. In an article for F1000 Medicine Reports, Seiji Shiota and Yoshio Yamaoka discuss the p ...

Recommended for you

Investigational drug improves sleep disorder among the blind

Jun 17, 2013

An investigational new drug significantly improved a common and debilitating circadian rhythm sleep disorder that frequently affects people who are completely blind, a multicenter study finds. The results were presented Monday ...

US: 'Pay to delay' generic drugs can be illegal (Update)

Jun 17, 2013

The Supreme Court ruled Monday that deals between pharmaceutical corporations and their generic drug competitors, which government officials say keep cheaper forms of medicine off the market, can be sometimes be illegal and ...

Medications to prevent clots not reaching some patients

Jun 14, 2013

Researchers at Johns Hopkins report that hospitalized patients do not receive more than one in 10 doses of doctor-ordered blood thinners prescribed to prevent potentially lethal or disabling blood clots, a decision they say ...

User comments

More news stories

Study suggests new approach to fight lung cancer

Recent research has shown that cancer cells have a much different – and more complex – metabolism than normal cells. Now, scientists at The University of Texas at Dallas have found that exploiting these differences might ...